Tilray Brands (TSE:TLRY) Stock Price Up 11.2% - What's Next?

Key Points

• Tilray Brands' stock price increased by 11.2%, reaching as high as C$1.60 before closing at C$1.59 during mid-day trading.
• The company has a market cap of C$985.88 million and shows a P/E ratio of -3.70, indicating potential growth challenges despite recent stock performance.
• Tilray Brands is primarily focused on the Canadian market, with a significant portion of its sales from medical and recreational cannabis, and has U.S. exposure through CBD and beer products.

Tilray Brands, Inc. (TSE:TLRY - )'s share price rose 11.2% during mid-day trading on Monday . The company traded as high as C$1.60 and last traded at C$1.59. Approximately 1,807,097 shares traded hands during mid-day trading, a decline of 7% from the average daily volume of 1,937,907 shares. The stock had previously closed at C$1.43.

Tilray Brands Stock Performance

The stock's 50-day moving average price is C$0.81 and its 200-day moving average price is C$0.85. The company has a market cap of C$985.88 million, a P/E ratio of -3.70 and a beta of 2.19. The company has a debt-to-equity ratio of 10.76, a current ratio of 2.54 and a quick ratio of 2.16.

Tilray Brands Company Profile

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.